Literature DB >> 3131425

Identification of a nuclear factor that binds to a conserved sequence of the I-A beta gene.

A Celada1, M Shiga, M Imagawa, J Kop, R A Maki.   

Abstract

Human and murine class II genes of the MHC show a striking homology 50 to 120 bp upstream of the transcription start site. This area is composed of two conserved sequences (a 13-mer and an 8-mer separated by 19 to 20 bp). Recently, these conserved sequences have been identified as cis-acting transcriptional regulatory elements. We have sought nuclear factors that bind specifically to an upstream fragment (-245 to +75 bp) of the murine I-A beta chain gene that contains the conserved sequences by application of a modified gel electrophoresis DNA binding assay. We report here the identification of a nuclear factor whose binding site overlaps the 8-mer conserved sequence. This factor is present in murine B and T lymphocytes, macrophages, mastocytes, fibroblasts, and human B lymphocytes and macrophages. The binding site was defined by using DNase I and dimethylsulfate protection assays. The putative binding sequence is closely related to the sequence, CCAAT, which is often found associated with the promoter of a gene and is recognized by the transcriptional factors CCAAT-binding transcription factor and nuclear factor I. Oligonucleotides that contain the binding site sequences for nuclear factor I and the alpha-globin CCAAT element, however, do not compete for binding of the nuclear factor to the sequence identified here, suggesting that, in spite of the similarity of the binding sequence, the nuclear factor identified in this report may be different. This nuclear protein may be one of the trans-acting factors that mediate transcription of class II genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131425

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice.

Authors:  C Herrero; L Marqués; J Lloberas; A Celada
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Sequences of human immunoglobulin switch regions: implications for recombination and transcription.

Authors:  F C Mills; J S Brooker; R D Camerini-Otero
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

Review 4.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  The same CCAAT box-binding factor binds to the promoter of two coordinately regulated major histocompatibility complex class II genes.

Authors:  M J Kern; J G Woodward
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

7.  Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors.

Authors:  R L Dedrick; P P Jones
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 8.  Control of transcription at the murine A alpha locus.

Authors:  M Boothby; H C Liou; P W Finn; E Gravallese; L H Glimcher
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

9.  DNA binding of the mouse class II major histocompatibility CCAAT factor depends on two components.

Authors:  A Celada; R A Maki
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

10.  Evidence for multiple major histocompatibility class II X-box binding proteins.

Authors:  A Celada; R Maki
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.